Przejdź do zawartości
Merck

[Allopurinol hypersensitivity syndrome: Liver transplantation after treatment of asymptomatic hyperuricaemia].

Deutsche medizinische Wochenschrift (1946) (2014-11-26)
S E Miederer, K O Miederer
ABSTRAKT

A 41 year old patient started treatment with 300 mg/d allopurinol for asymptomatic hyperuricaemia (9,2 mg/dl). 4 weeks later he developed exfoliative skin lesions with haemorrhage, fever, eosinophilia and acute liver and renal failure, typical for an allopurinol hypersensitivity syndrome (AHS).An orthotopic liver-transplantation was performed. The AHS is a serious iatrogenic disease. 2 % of the treated patients develop a skin rash. 0,4 % of these patients experience suddenly and unforeseen a severe hypersensitivity with a mortality of 14-30 %. An early diagnosis is often very difficult. In the pathogenesis different causes are discussed. A hereditary component is involved. Of essential importance is the amount of the starting dose, the kidney function and concomitant drugs. In an asymptomatic hyperuricaemia the application of allopurinol is not indicated. If strong indications are present, the allopurinol therapy has to start with the lowest dose (100 mg/d). If required this dose should be increased under consequent supervision only.

MATERIAŁY
Numer produktu
Marka
Opis produktu

USP
Amoxicillin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Amoxicillin, 95.0-102.0% anhydrous basis
Sigma-Aldrich
Allopurinol, xanthine oxidase inhibitor
Supelco
Amoxicillin trihydrate, VETRANAL®, analytical standard
Amoxicillin trihydrate, European Pharmacopoeia (EP) Reference Standard
Supelco
Amoxicillin trihydrate, Pharmaceutical Secondary Standard; Certified Reference Material
Amoxicillin trihydrate for performance verification, European Pharmacopoeia (EP) Reference Standard
Supelco
Allopurinol, Pharmaceutical Secondary Standard; Certified Reference Material
Allopurinol, European Pharmacopoeia (EP) Reference Standard